Taysha Gene Therapies Inc Sustainability Reports
A clinical-stage biotechnology company focused on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00TJXFDQ0
2 reports from 2021 to 2023